{"id":66721,"date":"2026-08-18T14:08:15","date_gmt":"2026-08-18T18:08:15","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/trade-crisis-looms-as-u-s-canada-deadline-nears-buddy-carter-eyed-for-fda\/66721\/"},"modified":"2026-08-18T14:08:15","modified_gmt":"2026-08-18T18:08:15","slug":"trade-crisis-looms-as-u-s-canada-deadline-nears-buddy-carter-eyed-for-fda","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/trade-crisis-looms-as-u-s-canada-deadline-nears-buddy-carter-eyed-for-fda\/66721\/","title":{"rendered":"Trade Crisis Looms as U.S.-Canada Deadline Nears; Buddy Carter Eyed for FDA"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>U.S. and Canadian negotiators are in last-minute talks<\/strong> to avert a <strong>50% tariff<\/strong> on <strong>$20 billion<\/strong> worth of Canadian goods, set to trigger at <strong>12:01 a.m. Wednesday<\/strong>.<\/li>\n<li><strong>Rep. Buddy Carter (R-GA)<\/strong> has emerged as a &quot;dark horse&quot; candidate for <strong>FDA Commissioner<\/strong>, following the recent resignation of <strong>Marty Makary<\/strong>.<\/li>\n<li><strong>Canadian Prime Minister Mark Carney<\/strong> described the trade negotiations as <em>&quot;intense and delicate,&quot;<\/em> with auto sector tariffs and provincial alcohol restrictions remaining major sticking points.<\/li>\n<li><strong>The proposed tariffs<\/strong> would impact a wide range of products, from <strong>lumber and steel<\/strong> to <strong>hockey sticks and tongue depressors<\/strong>, posing what some businesses call an <em>&quot;existential threat.&quot;<\/em><\/li>\n<\/ul>\n<h2>U.S.-Canada Trade Standoff Hits Critical Midnight Deadline<\/h2>\n<p>Negotiators from the <strong>United States<\/strong> and <strong>Canada<\/strong> are locked in high-stakes discussions in Washington to prevent a massive escalation in trade hostilities. <strong>U.S. President Donald Trump<\/strong> has threatened to impose <strong>50% tariffs<\/strong> on approximately <strong>$20 billion<\/strong> in Canadian exports if a deal is not reached by the midnight deadline on <strong>August 19<\/strong>.<\/p>\n<p>Canadian <strong>Trade Minister Dominic LeBlanc<\/strong> and Chief Negotiator <strong>Janice Charette<\/strong> met with <strong>U.S. Trade Representative Jamieson Greer<\/strong> and <strong>Commerce Secretary Howard Lutnick<\/strong> for nearly two hours on Monday. While the <strong>White House<\/strong> is pushing for the removal of retaliatory Canadian tariffs on U.S. autos and the return of American liquor to provincial shelves, Canada is seeking relief from existing <strong>Section 232<\/strong> industrial tariffs.<\/p>\n<p><em>Market analysts warn that a failure to reach a &quot;d\u00e9tente&quot; could disrupt critical supply chains and jeopardize millions of jobs<\/em> that rely on the <strong>USMCA<\/strong> framework. <strong>Prime Minister Mark Carney<\/strong> has reportedly spoken with <strong>President Trump<\/strong> directly, though he cautioned that Canada is preparing for &quot;all eventualities,&quot; including a full schedule of counter-tariffs.<\/p>\n<h2>Rep. Buddy Carter Considered for FDA Commissioner Role<\/h2>\n<p>In a significant potential shift for federal health policy, <strong>Rep. Buddy Carter (<a href=\"\/stock\/GA-01\">GA-01<\/a>)<\/strong> is being considered by the <strong>White House<\/strong> as the next commissioner of the <strong>Food and Drug Administration (FDA)<\/strong>. A source familiar with the administration&#39;s thinking confirmed that Carter is &quot;interested&quot; in the role, citing his unique combination of legislative experience and three decades as a licensed pharmacist.<\/p>\n<p>Carter, a staunch ally of the administration who is set to leave Congress at the end of the year, would represent a pivot from previous shortlists. As the current <strong>Chairman of the House Subcommittee on Health<\/strong>, he has been a vocal advocate for <strong>drug supply chain sovereignty<\/strong> and the <strong>FDA Modernization Act 3.0<\/strong>, which aims to reduce animal testing in drug development.<\/p>\n<p>The potential appointment comes at a turbulent time for the agency following the departure of <strong>Marty Makary<\/strong>. If nominated, Carter is expected to focus on <strong>lowering drug costs<\/strong>, addressing <strong>Pharmacy Benefit Manager (PBM)<\/strong> practices, and accelerating the domestic manufacturing of essential medications to reduce reliance on foreign adversaries.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways U.S. and Canadian negotiators are in last-minute talks to avert a 50% tariff on $20 billion worth of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[4179,4332,4335,5833,7253,8763,8945,17708,21775],"class_list":["post-66721","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-tariffs","tag-trade-war","tag-donald-trump","tag-fda","tag-us-canada-trade","tag-healthcare-policy","tag-mark-carney","tag-pbm","tag-buddy-carter-ga-01-stock-ga-01"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/66721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=66721"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/66721\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=66721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=66721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=66721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}